Clinical Pharmacology of Intravenously Administered Trimethoprim-Sulfamethoxazole

Pharmacokinetic studies of intravenously administered trimethoprim-sulfamethoxazole (TMP-SMX) were conducted in 11 patients with cancer while they received therapy with this drug combination for infection. Each patient received 160 mg of TMP and 800 mg of SMX every 8 h. The highest plasma concentrat...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Antimicrob Agents Chemother
Egile Nagusiak:	Grose, William E., Bodey, Gerald P., Loo, Ti Li
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1979
Gaiak:	Pharmacology and Therapeutics
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352681/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/464572/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.15.3.447
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!